Sevil SADRİ, Burcu POLAT, Berrin BALIK AYDIN, Hakan KOCAR, Aliihsan GEMİCİ, Huseyin Saffet BEKOZ, Ömür Gökmen SEVİNDİK, Fatma Deniz SARGIN

Evaluation of Neurological Imaging After Hematopoietic Stem Cell Transplantation In Adults

To investigate the risk factors for, and the incidence of, structural abnormalities in brain imaging among hematopoetic stem cell transplant (HSCT) patients and to correlate these findings with physical examinations. This study retrospectively reviewed all post-HSCT brain imaging taken in the researchers’ center between 2014 and 2020. 87 of 627 transplant patients were imaged. 34.5% (n = 30) were female. Age at transplant ranged from 18 to 74 years (median: 45). The most common malignancies were acute myeloid leukemia (AML; n = 21; 24.1%), 51 (58.6%) patients received allogeneic transplantation, and 36 (41.4%) received autologous transplantation. The imaging techniques were dispersed as follows: magnetic resonance imaging (MRI): 83.9% (n = 73), brain computed tomography (CT): 37.9% (n = 33), diffusion MRI: 19.5% (n = 17). 39.1% of the radiological images were normal; 20.7% showed disease recurrence; and 14.9% detected ischemic gliotic lesions. According to the imaging results, there was a statistically significant difference between age values (p = 0.013). Patients with PRES were younger than those with no pathologies in their imaging, while patients with infarcts and ischemic gliotic lesions were older than those with normal imaging (p = 0.001). Patien ts with disease recurrence were older than those with PRES but younger than those with infarctions (p = 0.001). Neurological complications are not uncommon in transplant cases. In managing transplantations, it should be remembered that the presence of radiologically positive findings, especially positives for cerebrovascular complications, can significantly reduce survival.

PDF

___

1. Openshaw H (2004) Neurological complications of hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR (eds) Thomas’ hematopoietic cell transplantation. Blackwell, Malden, pp 811-823.
2. Saiz A, Graus F (2004) Neurological complications of hematopoietic cell transplantation. Semin Neurol 24:427-434.
3. Weber C, Schaper J, Tibuussek D et al. (2008) Diagnostic and therapeutic implications of neurological complications following pediatric haematopoetic stem cell transplantation. Bone Marrow Transplant 41:253-259.
4. Uckan D, Cetin M, Yigitkanli I et al. (2005) Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 35:71-76.
5. Trullemans F, Grignard F, Van Camp B, Schots R. (2001) Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Euro J Haematol 67:94-99.
6. Coplin WM, Cochran MS, Levine SR, Crawford SW (2001) Stroke after bone marrow transplantation, frequency, etiology, and outcome. Brain 124:1043-1051,
7. Garrick R (2000) Neurological complications. In: Atkinson K (ed) Clinical bone marrow and blood stem cell transplantation. 2nd edn. Cambridge, Cambridge University Press, pp 958-979.
8. Iguchi A, Kobayashi R, Yoshida M, et al. (1999) Neurological complications after stem cell transplantation in childhood. Bone marrow transplant 24:647-652.
9. Antonini G, Ceschin V, Morino S, et al. (1998) Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 50:1441-1445.
10. Dowling MR, Li S, Dey BR, McAfee SLI, Spitzer TR, Chen YB, Ballen KK (2018) Neurological complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplant 53:199-206.
11. Ajithkumar T, Parkinson C, Shamshad F, Murray P (2007) Ifosfamide encephalopathy. Clin Oncol (R Coll Radiol) 19(2):108-114.
12. Howell JE, Szabatura AH, Hatfield SA, Nesbit SA (2008) Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant. J Oncol Pharm Pract 14(3):157-162.
13. Coplin WM, Cochran MS, Levine SR, Crawford SW. (2001) Stroke after bone marrow transplantation: frequency, etiology, and outcome. Brain 124(Pt 5):1043-1051.
14. Siegal D, Keller A, Xu W, et al. (2007) Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 13:1369-1379.
15. Faraci M, Lanino E, Dini G, et al. (2002) Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 59:1895-1904.
16. Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B (2017) Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 23:388-397.
17. Wong R, Beguelin GZ, de Lima M, et al. (2003) Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic hematopoietic stem cell transplantation. Br J Haematol 122:128-134.
18. Hammerstrom AE, Howell J, Gulbis A, Rondon G, Champlin RE, Popat U (2013) Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol 88:301-305.
19. Chen BT, Orlando Ortiz A, Dagis A, Torricelli Ch, Parker P, Openshaw H. (2019) Brain imaging findings in symptomatic patients after allogeneic haematopoetic stem cell transplantation: correlation with clinical outcome. European Society of Radiology 22:2273-2281.
20. Wiznitzer M, Packer RJ, August CS, Burkey ED (1984) Neurological complications of bone marrow transplantation in childhood. Ann Neurol 16:569-567.
21. Nishiguchi T, Mochizuki K, Shakudo M, Takeshita T, Hino M, Inoue Y (2009) CNS complications of hematopoietic stem cell transplantation. AJR2009;192:1003-1011.
22. McDonald GB (2010) Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology